Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 11, 2019

SELL
$115.94 - $166.74 $197,098 - $283,458
-1,700 Closed
0 $0
Q3 2018

Nov 08, 2018

SELL
$161.01 - $180.57 $1,288 - $1,444
-8 Reduced 0.47%
1,700 $286,000
Q2 2018

Jul 13, 2018

BUY
$146.33 - $183.18 $133,013 - $166,510
909 Added 113.77%
1,708 $295,000
Q1 2018

May 04, 2018

BUY
$135.59 - $157.16 $43,659 - $50,605
322 Added 67.51%
799 $120,000
Q4 2017

Feb 08, 2018

SELL
$131.06 - $150.39 $43,380 - $49,779
-331 Reduced 40.97%
477 $64,000
Q3 2017

Nov 13, 2017

SELL
$142.62 - $155.6 $3,422 - $3,734
-24 Reduced 2.88%
808 $118,000
Q2 2017

Aug 14, 2017

BUY
N/A
832
832 $129,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.99B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Mckinley Capital Management LLC Portfolio

Follow Mckinley Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Mckinley Capital Management LLC with notifications on news.